C ellular metabolism is tightly coordinated with the needs of the existing cellular state. Dividing cells must duplicate their cellular components and synthesize large amounts of proteins, lipids and DNA. Yet how metabolic processes are regulated to efficiently generate this material needed for cell division is only beginning to be understood. On page 426, Wang et al. 1 now reveal a direct link between the regulation of the cell cycle and that of cell metabolism.
D-type cyclin proteins and their catalytic binding-partner enzyme, (either one of the cyclin-dependent kinases CDK4 or CDK6), are required for cell division. They exhibit peak activity 2 during the early cell-cycle stage known as the G1 phase, when the cell grows in size and synthesizes components needed for DNA replication and cell division. The protein retinoblastoma (Rb) is among the most extensively studied substrates of the cyclin D-CDK complex. Progression through G1 requires the action of E2F transcription factors; however, the activity of E2F proteins is blocked when they bind to Rb (ref.
3). Phosphorylation of Rb by the cyclin D-CDK complex releases E2F proteins from their inhibitory interaction with Rb, enabling cellcycle progression. Inhibition of CDK4 and CDK6 commonly causes cell-cycle arrest in cancer cells, mainly because the Rb-E2F complex is stabilized 4 . Some cancer cells die when treated with inhibitors of CDK4 and CDK6 (ref. 4) .
Investigating human tumour cells grown in vitro, Wang et al. found that CDK6 inhibition induces the death of cells that predominantly use the combination of cyclin D3 and CDK6. Unexpectedly, they discovered that this cell death did not require the presence of Rb. Wang and colleagues investigated how inhibition of CDK6 resulted in cell death that was independent of the role of Rb in cell-cycle regulation.
The authors searched for CDK targets that might be relevant to this process by looking for proteins that associate with the cyclin-CDK complex. This led to the identification of the enzymes phosphofructokinase 1 (PFK1) and pyruvate kinase M2 (PKM2). The authors demonstrated that these proteins are directly phosphorylated by a complex formed of the specific combination of cyclin D3 and CDK6.
PFK1 and PKM2 each exist in both dimeric and tetrameric forms, with the tetrameric forms being more active 5, 6 . Tests to investigate the effect of phosphorylation of these enzymes gave results consistent with a model in which phosphorylation inhibits the activities of PFK1 and PKM2 by reducing the formation of tetramers in favour of the less-active dimers.
PFK1 and PKM2 function in glycolysis, a key metabolic pathway that breaks down glucose through a series of intermediates to generate the molecule pyruvate. A reduction in the activities of PFK1 and PKM2 results in the accumulation of glycolytic intermediates 5, 6 . If this occurs, rather than progressing through glycolysis to give pyruvate, these intermediates can feed into metabolic pathways known as the pentose phosphate pathway and the serine synthesis pathway (Fig. 1 ). The former yields the carbohydrate ribose, and the latter the amino acids serine and glycine, which are all important substrates for nucleotide synthesis. The two pathways also generate the cofactor molecule NADPH and the antioxidant peptide glutathione, both of which can neutralize reactive oxygen species (ROS) 5, 6 of the glycolytic enzymes PFK1 and PKM2, these intermediates can enter the pentose phosphate (PP) pathway or the serine synthesis (SS) pathway, respectively. The action of these other pathways increases levels of nucleotide building blocks, the cofactor molecule NADPH and the peptide glutathione, and decreases the amount of reactive oxygen species (ROS), which can cause DNA damage. Wang et al. 1 provide evidence that the cell-cycle regulatory complex of cyclin D3 protein and the kinase enzyme CDK6, which is associated with the G1 phase of the cell cycle 2 , can inhibit the activity of PFK1 and PKM2, providing a direct link between the cell cycle and cellular metabolism.
material from low-quality samples 3, 10, 11 . And it can build on the techniques deployed in the current studies. We will not put out every new fire, but we will catch some -and improve our ability to respond to the ones that get away. Any illusions that this approach would be prohibitively expensive must be dispelled by the certainty of future outbreaks that will have billion-or trillion-dollar price tags and cause unacceptable human suffering. ■ 
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A sk beachgoers how mussels, barnacles and oysters attach themselves to rocks, and they will often guess that suction cups are involved. Actually, these shellfish use adhesives. But go a little deeper into the water, and you will find organisms that do use suckers: octopuses. These soft-bodied animals use suction cups for surface attachment, locomotion and grabbing their next meal. On page 396, Baik et al. 1 report adhesive patches that are synthetic mimics of octopus suckers. The authors go beyond simply copying suction cups by discovering a specific architectural feature that enhances adhesion.
Characterizing and mimicking biological attachment strategies is a booming research area. The two most prominent strategies are wet adhesion and dry adhesion. Mussels, seagrasses and bacteria belong to the wet-adhesive community of organisms: they deposit glue, and use it to stay in place for long periods, if not their entire lives. The underwater bonding achieved by such species cannot be matched by most synthetic adhesives, although some biomimetic compounds now exhibit adhesion strengths similar to those of their natural counterparts 2 . Dry adhesion is more typical of insects and geckos, which use hardened, hair-like or pad-like structures on their feet to walk up walls. Such adhesion is temporary, used for locomotion and often employed in dry environ ments. Efforts to mimic natural dry adhesives have also yielded highperformance, hard-structured adhesives in the past few years (see ref. 3 , for example).
into the pentose phosphate and serine synthesis pathways, increased NADPH and glutathione levels, and reduced the concentration of ROS. When the authors treated cells that express high levels of cyclin D3 and CDK6 with the drug palbociclib, which inhibits CDK4 and CDK6 activity, this resulted in cell death. However, cells treated with palbociclib and an antioxidant molecule survived. In addition, cells that expressed versions of PFK1 and PKM2 that cannot be phosphorylated by cyclin D3-CDK6 were substantially protected from ROS accumulation and cell death caused by palbociclib. These results indicate that an increase in ROS generated downstream of PFK1 and PKM2 activation is responsible for the cell death seen after palbociclib treatment.
By providing evidence for a direct link between the cell cycle and cell metabolism, the work by Wang and colleagues raises a fundamental question that has largely been overlooked by biologists: how does cell metabolism intersect with the cell cycle? The biosynthetic requirements of proliferating cells have become evident as a result of the current attention given to cancer metabolism 8 . Wang et al.
show that a cell-cycle regulator directly influences metabolic processes; however, whether other cell-cycle regulators influence metabolism or whether metabolite levels are sensed by, and directly regulate, cell-cycle regulators remain open questions.
The regulation of metabolism by cell-cycle mediators makes intuitive sense. It has been argued 9 that temporal compartmentalization, in which different cellular processes occur at different times, enables the efficient coordination of metabolic activity and minimizes futile reactions. Temporal control of metabolic activity could also allow efficient channelling of products between the enzymes that synthesize the building blocks of macromolecules and those that use them. Consistent with this model, yeast grown in nutrientlimited conditions exhibits regular cycling of metabolic processes 10 . The cell cycle has metabolic needs linked to its specific stages, and so components of the cell-cycle process itself would be fitting drivers of metabolic cycling. For example, the amplification of nucleotide synthesis in the G1 phase, which immediately precedes the S phase of the cell cycle in which DNA is replicated, and the downregulation of nucleotide synthesis at other stages of the cell cycle, would limit unnecessary nutrient usage and energy expenditure. How PFK1 and PKM2 phosphorylation levels vary during the cell cycle was not addressed by Wang and colleagues.
Given that the cyclical activity of CDK6 is at its peak during the G1 phase 2 , it could be predicted that PFK1 and PKM2 phosphorylation also cycle and exhibit peak levels during G1, resulting in maximum production of nucleotide building blocks just before
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How to suck like an octopus
Rubber sheets that reversibly bind and release substrates have been made by copying a subtlety in the shape of octopus suckers. The findings reveal how macro-scale biological structures can influence function. See Letter p.396 DNA replication. In yeast, DNA replication is restricted to the phase of their metabolic cycle when oxygen consumption is minimal 10 . This is thought 11 to preserve genome integrity by protecting replicating DNA from oxidative damage, which can potentially cause mutations. Wang and colleagues' observation that human cells can increase their production of both NADPH and glutathione as a consequence of the action of a G1-phase-associated kinase might be an alternative mechanism to reduce the concentration of ROS just before DNA replication.
Drugs targeting cancer metabolism are beginning to enter the clinic 12 . The transformation of healthy cells into cancer cells is accompanied by extensive metabolic changes, but which metabolic reactions are essential for proliferation is unclear. It seems reasonable to speculate that the metabolic processes directly regulated by the cell cycle are those most essential for cell division.
Wang et al. transplanted 33 samples of human tumour cells into mice and treated them with ribociclib, another inhibitor of CDK4 and CDK6. This reduced the growth rate for most of the tumours, probably because of Rb sequestration of E2F transcription factors and cell-cycle arrest, but did not cause the tumours to shrink. However, the three tumours that had high levels of 
